These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11954750)

  • 21. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization--in HIV-Infected and HIV-uninfected children.
    Madhi SA; Adrian P; Kuwanda L; Cutland C; Albrich WC; Klugman KP
    J Infect Dis; 2007 Dec; 196(11):1662-6. PubMed ID: 18008250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protecting children with HIV against pneumococcal disease.
    Meehan A; Mackenzie G; Shingadia D; Booy R
    Lancet Infect Dis; 2009 Jul; 9(7):394-5. PubMed ID: 19555896
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization against pneumococcal disease in HIV-infected patients: conjugate versus polysaccharide vaccine before or after reconstitution of the immune system (CTN-147).
    Slayter KL; Singer J; Lee TC; Kayhty H; Schlech WF
    Int J STD AIDS; 2013 Mar; 24(3):227-31. PubMed ID: 23535358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of three doses of a five-valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection.
    King JC; Vink PE; Farley JJ; Smilie M; Parks M; Lichenstein R
    Pediatrics; 1997 Apr; 99(4):575-80. PubMed ID: 9093301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.
    Munier AL; de Lastours V; Porcher R; Donay JL; Pons JL; Molina JM
    Int J STD AIDS; 2014 Dec; 25(14):1022-8. PubMed ID: 24676129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination.
    Bhorat AE; Madhi SA; Laudat F; Sundaraiyer V; Gurtman A; Jansen KU; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
    AIDS; 2015 Jul; 29(11):1345-54. PubMed ID: 25888646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients.
    Breiman RF; Keller DW; Phelan MA; Sniadack DH; Stephens DS; Rimland D; Farley MM; Schuchat A; Reingold AL
    Arch Intern Med; 2000 Sep; 160(17):2633-8. PubMed ID: 10999977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.
    Yildirim I; Shea KM; Pelton SI
    Infect Dis Clin North Am; 2015 Dec; 29(4):679-97. PubMed ID: 26610421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pneumococcal vaccination and HIV infection.
    Moore D; Nelson M; Henderson D
    Int J STD AIDS; 1998 Jan; 9(1):1-7. PubMed ID: 9518008
    [No Abstract]   [Full Text] [Related]  

  • 31. Active immunization in HIV-infected patients.
    Pau AK; McNicholl IR; Pursell KJ
    Pharmacotherapy; 1996; 16(2):163-70. PubMed ID: 8820461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An audit of pneumococcal and hepatitis vaccination in an outpatient HIV clinic.
    Hunter MG; Post JJ
    Sex Health; 2012 Nov; 9(5):495-6. PubMed ID: 22950965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polysaccharide pneumococcal vaccination of nephrotic children at disease onset-long-term data.
    Aoun B; Wannous H; Azéma C; Ulinski T
    Pediatr Nephrol; 2010 Sep; 25(9):1773-4. PubMed ID: 20238227
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of pneumococcal disease through vaccination.
    Gentile A; Bazán V
    Vaccine; 2011 Sep; 29 Suppl 3():C15-25. PubMed ID: 21896348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pneumococcal vaccination: yes or no.
    Sharda KB
    Indian Pediatr; 2008 Jun; 45(6):519. PubMed ID: 18599950
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study.
    Cohen C; von Mollendorf C; de Gouveia L; Lengana S; Meiring S; Quan V; Nguweneza A; Moore DP; Reubenson G; Moshe M; Madhi SA; Eley B; Hallbauer U; Finlayson H; Varughese S; O'Brien KL; Zell ER; Klugman KP; Whitney CG; von Gottberg A;
    Lancet Glob Health; 2017 Mar; 5(3):e359-e369. PubMed ID: 28139443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pneumococcal vaccine response in human immunodeficiency virus-infected patients.
    Swiatlo E; Benton K; Briles DE
    J Infect Dis; 1996 Mar; 173(3):777-8. PubMed ID: 8627053
    [No Abstract]   [Full Text] [Related]  

  • 38. Pneumococcal vaccination for Indian children.
    Levine OS; Cherian T
    Indian Pediatr; 2007 Jul; 44(7):491-6. PubMed ID: 17684301
    [No Abstract]   [Full Text] [Related]  

  • 39. [Impact of invasive pneumococcal infection in children].
    Sáez-Llorens X
    An Esp Pediatr; 2002 Nov; 57(5):391-3. PubMed ID: 12467540
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children.
    Ditse Z; Adrian PV; Kuwanda L; Madhi SA
    Vaccine; 2013 Sep; 31(40):4421-7. PubMed ID: 23845819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.